08.06.2024 - GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved AREXVY (Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted) for the prevention of RSV lower respiratory tract disease (LRTD) in adults 50 through . Seite 1
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1
Clinical development program continues to evaluate safety and immunogenicity.
Vineet Dua, MD, Joins Hamilton Cardiovascular Institute chattanoogan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chattanoogan.com Daily Mail and Mail on Sunday newspapers.
Marie Mann Stacy of Hampton Bays Remembered for Generosity danspapers.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from danspapers.com Daily Mail and Mail on Sunday newspapers.
West Chester Community Church To Celebrate 150 Years This Weekend kciiradio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kciiradio.com Daily Mail and Mail on Sunday newspapers.